Description
HQ-STAR 200 contains hydroxychloroquine, a medicine primarily used for rheumatoid arthritis, systemic lupus erythematosus (SLE), discoid lupus, and the prevention or treatment of malaria.
How HQ-STAR 200 Works
-
Autoimmune diseases: Hydroxychloroquine modulates immune cell action, reducing inflammation and abnormal immune response.
-
Malaria: Kills parasites in red blood cells, preventing growth and spread.
-
Other uses: Sometimes used for related autoimmune disorders (psoriatic arthritis, light-induced rashes), and investigated for type 2 diabetes and dyslipidemia.
Uses
-
Rheumatoid arthritis: Reduces pain, stiffness, and swelling in joints.
-
Lupus (SLE, discoid): Improves joint pain, skin rashes, fatigue, and kidney or organ involvement.
-
Malaria: For both prevention (chemoprophylaxis) and treatment (only in areas where malaria is not resistant).
-
Polymorphous light eruption, dermatological autoimmune conditions: Occasionally prescribed for these as well.
Common Side Effects
-
Headache, dizziness, blurred vision, stomach pain, vomiting, nausea, loss of appetite, diarrhea, skin rash, itching, mood changes, photosensitivity.
-
Rare/serious: Retinal damage (vision loss)—requires regular eye exams for long-term users.
-
Less common: Muscle weakness, pigment changes (skin/hair), low blood cell counts.
Directions & Safety
-
Take with food or milk to reduce stomach upset.
-
Dosing and frequency depend on indication; follow healthcare provider directions strictly.
-
Not recommended for severe eye, liver, or kidney disease, or in people with significant arrhythmia history.
-
Inform doctor if pregnant, breastfeeding, or on medications that may affect heart rhythm or immune system.
Ban & Availability
Hydroxychloroquine 200 mg tablets are not banned in India. HQ-STAR 200 is prescription-only and widely available for approved indications.
HQ-STAR 200 is an immunomodulatory and antimalarial drug widely used under medical supervision for autoimmune diseases and malaria treatment/prophylaxis.
Leave a Reply